Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein
US9840550B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2013 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Oct 1, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention deals with innovative compounds and compositions for preventing and/or treating a newly discovered detrimental mechanism, which blocks the endogenous myelin repair capacity of the adult nervous system (NS) in diseases associated with the expression of HERV-W envelope protein (ENV), in particular of its MSRV subtype.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.